We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Adtran
ADTN
$846M
| $262K | ﹤0.01% |
19,131
-3,267
| -15% | -$45.2K |
|
1602
CTS Corp
CTS
$1.72B
| $261K | ﹤0.01% |
8,875
-158
| -2% | -$4.63K |
|
|
HT
1603
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $261K | ﹤0.01% |
15,242
+1,254
| +9% | +$22.6K |
|
|
RUTH
1604
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $261K | ﹤0.01% |
10,194
-882
| -8% | -$21.6K |
|
|
BID
1605
DELISTED
Sotheby's
BID
| $261K | ﹤0.01% |
6,915
+898
| +15% | +$36K |
|
1606
ATN International
ATNI
$367M
| $260K | ﹤0.01% |
4,605
+1,476
| +47% | +$97.8K |
|
|
AXON
1607
Axon Enterprise
AXON
$39.6B
| $260K | ﹤0.01% |
4,780
-79
| -2% | -$4.05K |
|
1608
Badger Meter
BMI
$3.7B
| $260K | ﹤0.01% |
4,668
+578
| +14% | +$32.1K |
|
1609
Prestige Consumer Healthcare
PBH
$2.32B
| $260K | ﹤0.01% |
8,698
+1,232
| +17% | +$35.3K |
|
|
ARI
1610
Apollo Commercial Real Estate
ARI
$888M
| $259K | ﹤0.01% |
+14,245
| New | +$256K |
|
1611
US Physical Therapy
USPH
$1.13B
| $259K | ﹤0.01% |
2,465
+222
| +10% | +$23.9K |
|
|
CRAY
1612
DELISTED
Cray, Inc.
CRAY
| $259K | ﹤0.01% |
9,932
-129
| -1% | -$3K |
|
1613
Boston Properties
BXP
$10.8B
| $258K | ﹤0.01% |
1,930
-5,132
| -73% | -$659K |
|
|
HAYN
1614
DELISTED
Haynes International, Inc.
HAYN
| $258K | ﹤0.01% |
7,844
-126
| -2% | -$4.07K |
|
1615
Akamai
AKAM
$18.1B
| $257K | ﹤0.01% |
3,590
-8,762
| -71% | -$594K |
|
1616
Pinnacle Financial Partners Inc
PNFP
$14.7B
| $257K | ﹤0.01% |
4,700
-447
| -9% | -$24.7K |
|
|
NUVA
1617
DELISTED
NuVasive, Inc.
NUVA
| $257K | ﹤0.01% |
4,522
-121
| -3% | -$6.43K |
|
1618
NBT Bancorp
NBTB
$2.69B
| $256K | ﹤0.01% |
7,113
+356
| +5% | +$13.1K |
|
|
ADAM
1619
Adamas Trust
ADAM
$790M
| $256K | ﹤0.01% |
10,493
+1,213
| +13% | +$29.8K |
|
|
RAVN
1620
DELISTED
Raven Industries Inc
RAVN
| $256K | ﹤0.01% |
6,667
+657
| +11% | +$24.9K |
|
1621
Northwest Bancshares
NWBI
$2.24B
| $255K | ﹤0.01% |
15,040
+784
| +5% | +$13.9K |
|
1622
Revvity
RVTY
$12.3B
| $255K | ﹤0.01% |
2,650
-4,301
| -62% | -$387K |
|
1623
Insteel Industries
IIIN
$614M
| $251K | ﹤0.01% |
12,016
+2,450
| +26% | +$53.9K |
|
1624
Malibu Boats
MBUU
$558M
| $251K | ﹤0.01% |
+6,341
| New | +$262K |
|
|
RWT
1625
Redwood Trust
RWT
$636M
| $251K | ﹤0.01% |
15,549
+3,103
| +25% | +$49K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.